Genesis Healthcare Surges
Wow. It is amazing what a short analyst report can do to a stock, when it upgrades the recommendation to “Buy” with a price target that is 50% above the current price. That is what happened to Genesis Healthcare yesterday, after Chad Vanacore of Stifel wrote about the company and the improved outlook for skilled nursing in general. The previous closing price was $1.31 per share, and it surged by 26% to $1.65 in early trading on heavier than usual volume. Why? Signs of stabilization in the company’s core portfolio, improved reimbursement outlook for 2019 and beyond, a de-levering of the balance sheet and the divestiture of 55 facilities with unprofitable leases. That doesn’t mean it is... Read More »
The Warning Signs Were There
With assisted living occupancy now at an eight-year low, the reasons seemed very obvious a few years ago. I am a hoarder. I like to keep reports, articles, magazines and anything else of interest pertaining to seniors housing and care. So, last night I was cleaning up some papers stacked in my office and came across one of Jerry Doctrow’s first blogs since retiring from Stifel Nicolaus in 2015. Dated January 6, 2016, it was called, “Why Near-Term Trends Could Spell Trouble for Senior Housing.” As I re-read it, all I thought was, why didn’t more people see the problem back then? NIC MAP had just come out with its most recent quarterly data on occupancy and construction, and while not... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
